If you've been researching skin picking disorder, you may have come across references to the Griesemer Index, a scoring system used in clinical and research contexts to measure dermatillomania severity. It's not commonly discussed outside of academic papers, but it's a useful tool to understand, both for making sense of study results and for using it yourself to track progress in recovery.
The Griesemer Index (also referred to as the Griesemer Scale) is a clinician-administered rating tool that quantifies the extent and severity of skin picking across different body regions. It was developed to provide a standardised, objective measure of picking that researchers and clinicians could use consistently across studies and treatment settings.
The scale rates skin picking across five body zones:
Within each zone, severity is scored on the number of active lesions (picking sites) and the degree of tissue damage present. Scores are totalled to give an overall severity index. The higher the score, the more extensive and severe the active picking.
The Griesemer Index is used as an outcome measure in clinical trials of dermatillomania treatments. When a study reports that a treatment produced a significant reduction in Griesemer scores, this means that participants had fewer and less severe active picking sites after treatment than before, a direct, physical measure of improvement rather than a purely self-reported one.
The SaveMySkin randomised controlled trial, currently the largest RCT of a digital self-help programme for excoriation disorder, used the Griesemer Index as one of its primary outcome measures. The trial found a Cohen's d effect size of 0.79 on picking-related outcomes at 12 weeks, representing clinically meaningful improvement in Griesemer scores in the treatment group compared to waitlist controls.
"The Griesemer Index matters because it measures the actual physical state of the skin, not just how someone feels about their picking. It gives researchers a reliable anchor for comparing treatment effects across studies."
While the Griesemer Index is designed for clinical administration, the underlying logic, cataloguing how many body zones are affected and how many active sites exist within each zone, is directly adaptable for personal tracking. A simplified self-version might involve:
| Body Zone | Active picking sites (count) | Severity (1 = minor, 3 = significant) |
|---|---|---|
| Face | ||
| Scalp | ||
| Arms & hands | ||
| Trunk | ||
| Legs & feet |
Recording this weekly provides a concrete, observable measure of how skin condition is changing over the course of recovery. It can be more immediately useful than trying to assess "how much" you're picking by memory, which is notoriously unreliable, partly because automatic picking episodes are poorly encoded in memory. The skin itself keeps a more accurate record than the mind does.
The Griesemer Index measures physical skin state, it doesn't capture the frequency or duration of picking episodes, the emotional distress associated with picking, the impact on quality of life, or the person's subjective experience of their condition. For this reason, clinical trials of dermatillomania treatments typically use multiple measures alongside the Griesemer: self-report scales for picking behaviour (such as the Skin Picking Scale-Revised), quality of life assessments, and anxiety or depression measures where relevant.
For personal use in recovery, the Index is best treated as one data point among several. Physical skin state matters enormously, and it changes in response to treatment, but it tells only part of the story. Tracking urge frequency, episode duration, emotional triggers, and self-compassion alongside skin state gives a fuller picture of how recovery is progressing.
Learning about your skin picking makes a real difference both on the inside and outside, with that awareness creating a ripple effect. If you're ready to explore a compassionate guide to kick-start your picking management, start here.